These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

422 related items for PubMed ID: 16451297

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina.
    Tardif JC, Ford I, Tendera M, Bourassa MG, Fox K, INITIATIVE Investigators.
    Eur Heart J; 2005 Dec; 26(23):2529-36. PubMed ID: 16214830
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Heart rate-lowering efficacy and respiratory safety of ivabradine in patients with obstructive airway disease: a randomized, double-blind, placebo-controlled, crossover study.
    Majewski S, Slomka S, Zielinska-Wyderkiewicz E, Ciebiada M, Gorski P.
    Am J Cardiovasc Drugs; 2012 Jun 01; 12(3):179-88. PubMed ID: 22409211
    [Abstract] [Full Text] [Related]

  • 26. Rate control with ivabradine: angina pectoris and beyond.
    Parakh N, Bhargava B.
    Am J Cardiovasc Drugs; 2011 Jun 01; 11(1):1-12. PubMed ID: 21090826
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Ivabradine: I(f) inhibition in the management of stable angina pectoris and other cardiovascular diseases.
    Tardif JC.
    Drugs Today (Barc); 2008 Mar 01; 44(3):171-81. PubMed ID: 18536779
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Heart rate reduction via selective 'funny' channel blockers.
    Bucchi A, Barbuti A, Baruscotti M, DiFrancesco D.
    Curr Opin Pharmacol; 2007 Apr 01; 7(2):208-13. PubMed ID: 17267284
    [Abstract] [Full Text] [Related]

  • 34. The Role of Ivabradine in the Management of Angina Pectoris.
    Giavarini A, de Silva R.
    Cardiovasc Drugs Ther; 2016 Aug 01; 30(4):407-417. PubMed ID: 27475447
    [Abstract] [Full Text] [Related]

  • 35. Ivabradine: recent and potential applications in clinical practice.
    Riccioni G.
    Expert Opin Pharmacother; 2011 Feb 01; 12(3):443-50. PubMed ID: 21254949
    [Abstract] [Full Text] [Related]

  • 36. [Stable angina pectoris. Effective symptom control and cardioprotection with ivabradine].
    MMW Fortschr Med; 2010 May 27; 152(21):102-3. PubMed ID: 20608138
    [No Abstract] [Full Text] [Related]

  • 37. Effects of ivabradine in patients with stable angina receiving β-blockers according to baseline heart rate: an analysis of the ASSOCIATE study.
    Tardif JC, Ponikowski P, Kahan T, ASSOCIATE Investigators.
    Int J Cardiol; 2013 Sep 30; 168(2):789-94. PubMed ID: 23138014
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Novel If current inhibitor ivabradine: safety considerations.
    Savelieva I, Camm AJ.
    Adv Cardiol; 2006 Sep 30; 43():79-96. PubMed ID: 16936474
    [Abstract] [Full Text] [Related]

  • 40. Efficacy and Safety of Ivabradine in Combination with Beta-Blockers in Patients with Stable Angina Pectoris: A Systematic Review and Meta-analysis.
    Nedoshivin A, Petrova PTS, Karpov Y.
    Adv Ther; 2022 Sep 30; 39(9):4189-4204. PubMed ID: 35842897
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.